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Abstract
$watermark-text

Proline dehydrogenase catalyzes the FAD-dependent oxidation of proline to Δ1- pyrroline-5carboxylate, which is the first step of proline catabolism. Here, we report the structures of proline
dehydrogenase from Deinococcus radiodurans in the oxidized state complexed with the proline
analog L-tetrahydrofuroic acid and in the reduced state with the proline site vacant. The analog
binds against the si face of the FAD isoalloxazine and is protected from bulk solvent by the α8
helix and the β1-α1 loop. The FAD ribityl chain adopts two conformations in the E-S complex,
which is unprecedented for flavoenzymes. One of the conformations is novel for the PRODH
superfamily and may contribute to the low substrate affinity of Deinococcus PRODH. Reduction
of the crystalline enzyme-inhibitor complex causes profound structural changes, including 20°
butterfly bending of the isoalloxazine, crankshaft rotation of the ribityl, shifting of α8 by 1.7 Å,
reconfiguration of the β1-α1 loop, and rupture of the Arg291-Glu64 ion pair. These changes
dramatically open the active site to facilitate product release and allow electron acceptors access to
the reduced flavin. The structures suggest that the ion pair, which is conserved in the PRODH
superfamily, functions as the active site gate. Mutagenesis of Glu64 to Ala decreases catalytic
efficiency 27-fold, which demonstrates the importance of the gate. Mutation of Gly63 decreases
efficiency 140-fold, which suggests that flexibility of the β1-α1 loop is essential for optimal
catalysis. The large conformational changes that are required to form the E-S complex suggest that
conformational selection plays a role in substrate recognition.

$watermark-text

Proline dehydrogenase (PRODH) catalyzes the first reaction of proline catabolism (Figure
1A).1 PRODH is an FAD-dependent enzyme that catalyzes the oxidation of L-proline to Δ1pyrroline-5-carboxylate (P5C). The electrons stored in the reduced flavin are subsequently
transferred to the electron transport chain for eventual ATP production. P5C forms an
equilibrium with its hydrolysis product glutamate γ-semialdehyde (GSA), which is oxidized
*
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to glutamate by the second enzyme of proline catabolism, NAD+-dependent P5C
dehydrogenase (P5CDH). PRODH and P5CDH are distinct enzymes in eukaryotes and
Gram-positive bacteria, whereas the two enzymatic activities are combined into a single
polypeptide chain, known as proline utilization A (PutA), in Gram-negative bacteria.2, 3

$watermark-text

PRODH is of interest because of its roles in apoptosis, cancer, and schizophrenia. In
eukaryotes, PRODH and P5CDH are localized to the inner mitochondrial membrane and
mitochondrial matrix respectively, and proline catabolism is important for establishing the
mitochondrial redox status.4, 5 Seminal work from Phang’s group has established that human
PRODH (aka proline oxidase or POX) is a tumor suppressor protein.5–13 POX expression is
induced by the tumor suppressor p53, and POX itself activates intrinsic and extrinsic
apoptotic pathways.8 Crucial to the role of POX as a tumor suppressor is its ability to
generate superoxide.5, 8, 14 Also, certain mutations in the gene encoding POX cause type I
hyperprolinemia,15 which is a risk factor for schizophrenia.16

$watermark-text

Crystal structures of PRODHs suggest that conformational changes are essential for
catalysis, but the details of these conformational changes have not been elucidated. We
previously determined structures of the PRODH domain of Escherichia coli PutA
(PutA86-669) complexed with proline and proline analogs,17, 18, 19 as well as a structure of
Bradyrhizobium japonicum PutA with a sulfate ion bound in the proline site.20 In all of
those structures, proline (or the analog) is completely buried, implying that the active site
opens to allow product release and closes again in response to substrate binding. Since the
structure of the empty PutA PRODH active site is unknown, it has not been possible to
deduce these conformational changes for PutA. We also reported a structure of the
monofunctional PRODH from Thermus thermophilus (TtPRODH) in a substrate-free
conformation.21 However, the corresponding structure of the closed, substrate-bound active
site is unknown. Thus, our understanding of how conformational changes facilitate catalysis
has been limited by difficulties in crystallizing the same PRODH in both the open
(substrate-free) and closed (substrate-bound) conformations. Although some information has
been gained by comparing the structures of PutA669-proline and ligand-free TtPRODH, this
comparison is problematic because it is unknown whether PutAs and monofunctional
PRODHs bind proline similarly. Another factor that complicates such a comparison is that
the PRODH domain of PutA makes tertiary structural contacts that are absent in
monofunctional PRODHs, and thus is unlikely that PutA PRODH domains and
monofunctional PRODHs exhibit similar degrees of flexibility.

$watermark-text

We therefore surveyed several monofunctional PRODHs in search of one that crystallizes in
the presence of the proline analog L-tetrahydrofuroic acid (THFA). This survey uncovered
Deinococcus radiodurans R1 PRODH (DrPRODH) as a suitable enzyme for determining the
structural changes that occur in monofunctional PRODHs during the reductive half-reaction
(Figure 1B). Herein we report high resolution crystal structures and kinetic studies of
DrPRODH, which provide new insight into substrate recognition by monofunctional
PRODHs and the conformational changes that accompany flavin reduction and product
release.

EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The gene encoding DrPRODH (NCBI RefSeq code NP_294538.1, 310 residues) in the
vector pMH1F was obtained from the Joint Center for Structural Genomics. The gene was
amplified by PCR and ligated into plasmid pKA8H using NdeI and BamHI sites. The
expressed protein includes an N-terminal His8 tag and Tobacco Etch Virus protease (TEVP)
site. The G63A mutant of DrPRODH was created with the QuickChange II site-directed
Biochemistry. Author manuscript; available in PMC 2013 December 18.
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mutagenesis kit (Agilent) using a forward primer of 5′GAACCTTGACCTGCTCGCCGAATTTATCGACAGCCCG-3′, and a reverse primer of
5′-CGGGCTGTCGATAAATTCCGCGAGCAGGTCAAGGTTC-3′. The E64A mutant of
DrPRODH was prepared similarly using a forward primer of 5′CTTGACCTGCTCGGCGCCTTTATCGACAGCCCGGCC-3′, and a reverse primer of 5′GGCCGGGCTGTCGATAAAGGCGCCGAGCAGGTCAAG-3′. The mutations were
confirmed using DNA sequencing.

$watermark-text

DrPRODH and mutants G63A and E64A were expressed in BL21(DE3)pLysS cells as
follows. Starter cultures of 10 mL were grown in LB media overnight and used to inoculate
3 L of LB broth. After the culture reached an optical density of OD600 = 0.8, 0.5 mM IPTG
was added to induce protein expression for 5 hours at 22 °C. The cells were collected by
centrifugation, resuspended in 50 mM Tris, 100 mM NaCl, 10 mM imidazole, and 5%
glycerol at pH 7.5, and frozen at −80 °C.

$watermark-text

DrPRODH and mutants G63A and E64A were purified as follows. The frozen cells were
thawed at 4 °C in the presence of protease inhibitors (0.1 mM TPCK, 0.05 mM AEBSF, 0.1
μM Pepstatin, 0.01 mM Leupeptin, 5μM E-64) and broken using sonication. The mixture
was centrifuged at 16500 rpm in an SS34 rotor for 1 hour at 4 °C, filtered through a 0.45 μm
filter (Millipore) and loaded to HisTrap HP column (5 mL) that had been equilibrated in 50
mM Tris, 300 mM NaCl, 10 mM imidazole, and 5% glycerol at pH 7.5. Washing steps with
the loading buffer supplemented with 10 mM imidazole followed by 30 mM imidazole were
performed. The protein was eluted with 300 mM imidazole. The histidine tag was removed
by incubating the protein with 0.2 mg/mL TEVP for 1 hour at 28 °C followed by dialysis at
4 °C against 50 mM Tris, 50 mM NaCl, and 5% glycerol at pH 7.5. The mixture was applied
to the HisTrap HP column to separate the cleaved protein, which appeared in the flowthrough, from the tag and TEVP. The cleaved protein was dialyzed overnight in the dark at 4
°C into 50 mM Tris, 0.5 mM EDTA, 0.5 mM DTT, and 5% glycerol at pH 7.8 in preparation
for anion exchange chromatography (HiTrap Q). The sample was loaded onto the column
using a buffer of 50 mM Tris and 5% glycerol at pH 7.8, and a linear NaCl gradient was
applied. DrPRODH eluted in the range 360 – 420 mM NaCl. The protein concentration was
estimated using the bicinchoninic acid method (Pierce kit) with bovine serum albumin as the
standard. The flavin contents of the purified mutants G63A and E64A were similar to that of
DrPRODH.
Crystallization and Crystal Soaking Experiments

$watermark-text

All crystallization experiments were performed at 22 °C using the sitting-drop method of
vapor diffusion with drops formed by mixing equal volumes of the reservoir and the protein
stock solutions. The latter solution consisted of 2.8 mg/mL DrPRODH in 50 mM Tris, 50
mM NaCl, 0.5 mM THP, 0.5 mM EDTA, 5% glycerol, and 400 mM THFA at pH 7.5. Initial
conditions were identified using commercially available crystal screens (Hampton
Research). Optimized crystals were grown using a reservoir solution of 0.2 M MgCl2, 25%
(w/v) PEG 3350, and 0.1 mM Bis-tris at pH 5.8. The crystals were cryoprotected with the
reservoir solution supplemented with 25% (v/v) PEG 200, picked up with Hampton loops,
and flash-cooled in liquid nitrogen. The space group is P212121 with unit cell dimensions of
a = 44 Å, b = 95 Å, and c = 136 Å. The asymmetric unit includes two enzyme-THFA
complexes and 40% solvent.
Crystals of DrPRODH with the FAD reduced (DrPRODHr) were obtained by soaking the
aforementioned crystals for ~17 minutes in 50 mM sodium dithionite, 0.2 M MgCl2, 25%
PEG 3350, 0.1 mM Bis-Tris pH 5.5, and 25% PEG 200. The crystal color changed from
deep yellow to colorless during soaking, which is consistent with reduction of the FAD. The
crystals were flash cooled in liquid nitrogen to trap the reduced enzyme conformation.
Biochemistry. Author manuscript; available in PMC 2013 December 18.
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X-ray Diffraction Data Collection, Processing, and Refinement

$watermark-text

Diffraction data were collected on beamlines 4.2.2 of the Advanced Light Source and 24-IDC of the Advanced Photon Source. The reflections were integrated with XDS22 and scaled
with SCALA23 (Table 1). The phase problem was solved using molecular replacement as
implemented in MOLREP.24 The search model was the (βα)8 barrel of Thermus
thermophilus PRODH (residues 37 – 279 of chain A of PDB code 2G37, 47 % identical to
DrPRODH). The correct solution had a correlation coefficient of 0.36 with two molecules in
the P212121 asymmetric unit. For reference, molecular replacement calculations that
assumed other primitive orthorhombic space groups yielded correlation coefficients of 0.26
– 0.31. The model from molecular replacement was used as the starting point for several
rounds of model building with COOT25 and refinement with PHENIX.26 Table 1 lists
refinement statistics.
The oxidized flavin exhibits two conformations in the THFA complex (Figure S1 of
Supporting Information). The two conformations have occupancies of 0.56 (conformation
A) and 0.44 (conformation B) and differ in the orientations of the 2′ and 3′ hydroxyl groups
of the ribityl chain. Justification for building two conformations was obtained by refining
the structure with single conformations of the FAD. For example, the Fo-Fc map calculated
after a refinement that included only conformation A at occupancy of 1.0 showed strong
features for the 2′-OH and 3′-OH ribityl groups of conformation B (Figure S1, blue cage).
Conversely, the map calculated after a refinement that included just conformation B at
occupancy of 1.0 showed strong features for the 2′-OH and 3′-OH ribityl groups of
conformation A (Figure S1, green cage).

$watermark-text

Enzyme Activity Assays

$watermark-text

All chemicals used during kinetic characterization were purchased from Fischer Scientific or
Sigma-Aldrich. All steady-state assays were conducted at 23 °C in 50 mM potassium
phosphate, 25 mM NaCl at pH 7.5. For all assays, Coenzyme Q1 (CoQ1) was used as the
electron acceptor with CoQ1 reduction monitored by the decrease in absorbance at 278 nm
using a molar extinction coefficient of 14.5 mM−1 cm−1.27 The Km for proline and kcat for
wild-type DrPRODH (0.25 μM) were determined by varying the concentration of proline (0
– 500 mM) while keeping CoQ1 constant (200 μM). Inhibition of wild-type DrPRODH
(0.25 μM) by THFA was analyzed by varying proline (10 – 500 mM) and THFA (0 – 200
mM), while keeping CoQ1 constant (200 μM). These assays were performed in a total
volume of 200 Vl per assay using a Powerwave XS microplate spectrophotometer (BioTek). The Km for CoQ1 and kcat for wild-type DrPRODH (0.25 μM) were determined by
varying CoQ1 (0 – 450 μM) and keeping proline constant (500 mM). For the DrPRODH
mutants G63A (11 μM) and E64A (6.3 μM), the Km for proline and kcat were determined by
varying proline (0 – 1000 mM) and holding CoQ1 constant (200 μM). The Km for CoQ1
and kcat for the DrPRODH mutants were determined by varying CoQ1 (10 – 450 μM) and
holding proline constant (500 mM). These assays were performed in a total volume of 150
μl by mixing enzyme and substrate solutions using a Hi-Tech Scientific SF-61DX2 stopped
flow instrument equipped with a 0.15 cm path length cell. Steady-state parameters were
calculated by fitting initial rate data to the Michaelis-Menten equation and inhibition data
were globally fit to a competitive inhibition model using Enzyme Kinetic Wizard
(SigmaPlot 12.0).

RESULTS
Structure of DrPRODHo-THFA
The crystal structure of oxidized DrPRODH (DrPRODHo) complexed with the proline
analog THFA was determined at 1.36 Å resolution (Table 1). It is the first structure of a
Biochemistry. Author manuscript; available in PMC 2013 December 18.
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monofunctional PRODH complexed with a proline analog and the highest resolution
structure of any PRODH or PutA.

$watermark-text

The DrPRODHo-THFA complex exhibits a distorted (βα)8 barrel fold in which the last
helix, denoted as α8 (residues 285-295), is located above the C-terminal ends of the strands
rather than alongside β8 as in the classic triosephosphate isomerase barrel (Figure 2A). This
fold is also observed in the structures of TtPRODH (Figure 2B) and PutA and is considered
to be a defining characteristic of the PRODH superfamily, which includes both
monofunctional PRODHs and PutAs. The root mean square deviation between DrPRODHoTHFA and TtPRODH is 1.2 Å; the variation from PutA PRODH domains is slightly higher
at 1.5 – 1.9 Å.
THFA binds between the si face of the FAD and α8 (Figure 2A). Arg291, Arg292, and
Lys98 form ion pairs with the carboxylate of THFA, while Leu257, Tyr278, Tyr288 provide
hydrophobic contacts with the pyrrolidine ring (Figure 3A). Arg291 and Arg292 are
stabilized by ion pairs with Glu64 and Glu295, respectively. The plethora of residues
clustered around THFA make the inhibitor and the si face of the flavin inaccessible to
solvent. The oxidized flavin exhibits two conformations, which is unprecedented for
PRODHs and PutAs (Figure 4A). Furthermore, we are unaware of another flavin
oxidoreductase that exhibits multiple flavin conformations in the E-S complex.

$watermark-text

The two conformations have occupancies of 0.56 (conformation A) and 0.44 (conformation
B). Interestingly, the two FAD conformations do not correspond to THFA-bound and
THFA-free states because the occupancy of THFA is clearly 1.0 (B-factor = 17.5 Å2).
Rather, the enzyme is able to bind THFA using either of two different FAD conformations.
The two FAD conformations differ in the orientations of the 2′ and 3′ hydroxyl groups of
the ribityl chain (Figures 4A and S1). In conformation A (yellow in Figure 4A), the 2′-OH
points toward the proline binding site, while the 3′-OH is oriented 180° away and interacts
with the carbonyl of Gly191. Conformation B is related to conformation A by a crankshaft
rotation around the C2′-C3′ bond. In conformation B (pink in Figure 4A), the 2′-OH is
tucked under the pyrimidine ring where it forms hydrogen bonds with the flavin N1 atom
and N-H group of Gly191, while the 3′-OH interacts with Glu295 of α8.

$watermark-text

Ribityl conformation A appears to be unique among the PRODH superfamily. Although it
resembles the ribityl of PutA86-669-THFA in that 2′-OH points into the proline site, the
other two hydroxyl groups of conformation A are rotated 180° from the corresponding
hydroxyls of PutA86-669-THFA (Figure 5A). Although the 4′-OH of DrPRODH overlaps
the 3′-OH of PutA86-669-THFA (Figure 5A), the two hydroxyls are nonequivalent because
they form different interactions. The 3′-OH of PutA86-669-THFA forms a hydrogen bond
with conserved Glu559 of α8 (Figure 3B), which corresponds to Glu295 of DrPRODH.
Glu295, however, adopts a different conformation and is thus unable to form an analogous
hydrogen bond with the 4′-OH (Figure 3B).
Ribityl B is more familiar. It is similar to the ribityl of ligand-free TtPRODH (Figure 5B). In
both structures, the 2′- and 3′-hydroxyls are below the pyrimidine ring, while the 4′-OH is
below the dimethylbenzene ring. One notable difference is that the 4′-OH of DrPRODH
ribityl B is located on the si face of the FAD, whereas that of TtPRODH is torsioned over to
the re side. The re side location allows the hydroxyl to engage a structurally conserved water
molecule that bridges the main chains of β5 and β6 in all PRODH and PutA structures
(Figure 5B).
The flavins of DrPRODH and PutA also differ in the position of the adenosine group (Figure
5A). Because of a rotation around the pyrophosphate, the adenine ring positions of the two

Biochemistry. Author manuscript; available in PMC 2013 December 18.
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structures differ by 13 Å. This difference was also noted in TtPRODH and is due to the
presence of an extra α-helix in PutAs that is absent in monofunctional PRODHs.21
Structure of DrPRODHr

$watermark-text

A 1.75 Å resolution structure of DrPRODHr was determined from a crystal of the
DrPRODHo-THFA complex that was soaked in sodium dithionite. Reduction causes large
conformational changes in the flavin, which are observed in both molecules in the
asymmetric unit. Large protein conformational changes are also observed in chain A of the
asymmetric unit, and the electron density map is consistent with release of THFA. In the
other chain, crystal contacts prevent large protein conformational changes, and the electron
density map suggests that an acetate ion replaces THFA. We note that PutA86-669
crystallized in PEG 3350 also has an acetate ion bound in the active site.28 The discussion
below focuses on chain A, since it provides information about conformational changes in
both the flavin and the protein.

$watermark-text

Reduction by dithionite induces substantial conformational changes in the flavin. The
reduced flavin exhibits a 20° butterfly bend in the isoalloxazine (Figure 4C), which contrasts
the planar isoalloxazine of the oxidized enzyme. Severe butterfly bending (20°–30°) has also
been observed in the dithionite-reduced flavin of PutA86-66928 and the covalently modified,
reduced flavins of N-propargylglycine-inactivated PRODH29 and PutA.30 The bending of
the flavin pushes the N5-N10 axis toward the proline binding site, which results in the si
face being convex. The reduced flavin of DrPRODHr exhibits just one ribityl conformation
(Figure 4B), which is nearly identical to the ribityl chains of the oxidized FAD in TtPRODH
and the reduced flavin in the N-propargylglycine-inactivated E. coli PutA PRODH domain30
(Figure 5C).

$watermark-text

Flavin reduction also dramatically changes the protein conformation. Upon flavin reduction,
α8 shifts away from the isoalloxazine by 1.7 Å, and the β1-α1 loop (residues 62 - 69)
withdraws from the active site by over 5 Å (Figure 6A). One major consequence of these
movements is the rupture of the Arg291-Glu64 ion pair, which links α8 and the β1-α1 loop
in the THFA complex. The electron density for the ion pair in the THFA complex is
exceptional, indicating that this interaction is quite strong (Figure 3A). Its rupture is thus a
significant event. Breaking of the ion pair causes Glu64 and Arg291 to separate from each
other. Glu64 is driven to the protein surface along with the rest of the β1-α1 loop (Figures
6A and 2B), although we note that electron density for the β1-α1 loop is relatively weak in
DrPRODHr, implying high mobility. In fact, density for the side chain of Glu64 in
DrPRODHr is absent, indicating that the side chain is disordered. Electron density for the
side chain of Arg291 is likewise weak, but suggests that the guanidinium group turns away
from the proline binding site (Figure 6A). Flavin reduction also induces disorder in another
key side chain of α8, Glu295, which hydrogen bonds with the FAD adenine and ribityl
groups in the THFA complex.
The large movements of α8 and the β1-α1 loop dismantle the proline binding site and
profoundly change the solvent accessibility of the flavin. In the THFA complex, the
isoalloxazine and THFA are buried beneath the Arg291-Glu64 ion pair (Figure 6B), and the
interaction between Glu295 and the ribityl seals the bottom of the active site (Figure 6B,
inset). In the reduced enzyme, the separation of Arg291 from Glu64 creates a large, solvent
exposed cavity in the upper part of the active site, which contains the isoalloxazine (Figure
6C). Furthermore, the combination of disorder in Glu295 and change in the ribityl
conformation creates a hole in the bottom of the active site of the reduced enzyme (Figure
6C, inset). Thus, active site of the reduced, ligand-free enzyme is open and the flavin is
highly solvent exposed.

Biochemistry. Author manuscript; available in PMC 2013 December 18.
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Kinetic Parameters of DrPRODH and DrPRODH β1-α1 Loop Mutants
The observation of large conformational changes in the β1-α1 loop induced by flavin
reduction and release of THFA prompted investigation of this loop using site-directed
mutagenesis. As described by White, et al., the β1-α1 loop harbors one of 9 conserved
sequence motifs that define the PRODH superfamily.21 This motif includes a Gly-Glu pair
that is present in all monofunctional PRODHs and PutAs and corresponds to Gly63-Glu64
of DrPRODH. These residues were therefore investigated by creating the site-directed
mutant enzymes G63A and E64A.

$watermark-text

The kinetic parameters for wild-type DrPRODH were first determined (Table 2). The values
of kcat and Km using proline as the variable substrate with fixed CoQ1 are 8.7 s−1 and 290
mM, respectively, resulting in a kcat/Km of 30 s−1M−1. For comparison, the corresponding
parameters of the closely related TtPRODH (47 % identical to DrPRODH) are kcat = 13 s−1,
Km = 27 mM.21 Those of the E. coli PutA are kcat = 5.2 s−1, Km = 42 mM.27 Thus, the Km
for proline of DrPRODH is higher than expected. The kinetic parameters were also
determined using CoQ1 as the variable substrate at fixed proline concentration. These values
are kcat = 14 s−1, Km = 155 μM. The corresponding values for TtPRODH are not available.
Those of the E. coli PutA are kcat = 3.4 s−1, Km = 110 μM.27 Finally, THFA was found to
inhibit DrPRODH competitively with proline. The estimated KI value of 38 mM is over 10
times higher than those of TtPRODH (1 mM21) and PutA (1.6 mM27). These results suggest
that the affinity of DrPRODH for proline is atypically low.

$watermark-text

Catalytic activity is severely impaired in the mutants G63A and E64A (Table 2). Using
proline as the varying substrate, kcat values of 0.08 s−1 and 0.055 s−1 were obtained for
G63A and E64A, respectively, which are over 100 times lower than that of DrPRODH. The
catalytic efficiencies of G63A and E64A for proline are 140-fold and 27-fold lower than that
of DrPRODH. Using CoQ1 as the varying substrate, the kcat values are 0.043 s−1 and 0.046
s−1 for G63A and E64A, respectively, which are 300-fold lower than that of DrPRODH. The
efficiencies of the mutants for CoQ1 are 60-fold lower relative to DrPRODH. In summary,
the kinetic analysis of G63A and E64A confirms the significance of the conserved sequence
motif and is consistent with the structures, which suggest that Gly63 is important for the
flexibility of the β1-α1 loop, and Glu64 is important for stabilizing the closed active site.

DISCUSSION
$watermark-text

The DrPRODH structures provide new information about the conformations populated by
monofunctional PRODHs during the reductive half-reaction (Figure 1B). In particular, the
DrPRODHo-THFA structure represents the E-S complex (state II, Figure 1B). The active
site of the E-S complex is closed, and the substrate is buried. The tight packing within the
complex is also observed in PutA86-669 (Figure 3B) and presumably helps align proline
with the flavin for hydride transfer. A water molecule is present in the E-S complex, which
bridges conserved Tyr193 and the THFA heteroatom (N atom of proline). An analogous
water molecule is also present in the PutA86-669-THFA complex (Figure 3B), suggesting
that it is conserved in the PRODH superfamily. It is tempting to speculate that this water
molecule hydrolyzes P5C to GSA. If so, the hydrolysis reaction occurs within the active site
rather than in solution as implied in Figure 1A and most Biochemistry textbooks and
literature articles on proline catabolism.
The E-S complexes of DrPRODH and PutA86-669 are very similar (Figure 3B). In both
cases, the inhibitor is completely buried between the si face of the FAD and α8. The
enzyme-inhibitor interactions and ion pair gate conformation are virtually identical in the
two structures. Thus, substrate recognition is highly conserved in the PRODH superfamily.
The only notable difference involves the conserved glutamate of α8 (Glu295 of DrPRODH
Biochemistry. Author manuscript; available in PMC 2013 December 18.
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and Glu559 of PutA). The different orientations of this side chain seem to be related to the
different conformations of the FAD adenosine groups. In DrPRODH, the adenine ring packs
against α8 and forms a hydrogen bond with Glu295 (Figure 3B). This interaction is not
possible in PutA because of the markedly different location of the adenosine (Figure 5A),
which is due to the presence of an extra α-helix in PutAs that is absent in monofunctional
PRODHs.21

$watermark-text

Given the sequence and structural conservation of the proline binding site, it is surprising
that DrPRODH has markedly lower substrate affinity than PutA and TtPRODH. One
possibility is that the FAD ribityl plays a role in tuning substrate affinity. DrPRODH is
unique in that two conformations of the ribityl are observed in the E-S complex, neither of
which is corresponds to that of the high affinity PutA86-669-THFA complex, although
conformation A is reminiscent of the flavin in PutA86-669-THFA. It is possible that
conformation B represents an inactive state and that a conformational change is required to
transform it to conformation A before hydride transfer occurs. If so, Glu295 may play a role
in this transformation since it hydrogen bonds with the 3′-OH of conformation B (Figure
4A). Additional structures of PRODH-THFA complexes would shed light on this issue.
Comparison of the DrPRODHo-THFA and DrPRODHr structures provides insight into
conformational changes that occur upon flavin reduction and product release (state II to state
IV in Figure 1B). These include severe bending of the isoalloxazine, dihedral rotation of the
ribityl chain, shifting of α8, reconfiguration of the β1-α1 loop, rupture of the conserved
Arg291-Glu64 ion pair, and disordering of Glu295.
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The structures suggest a scenario for how the enzyme moves from state II to state IV of the
reductive half-reaction. The butterfly bending of the isoalloxazine appears to initiate a
cascade of events that leads to product release. Bending of the ring system pushes the N5N10 axis of the flavin toward the newly formed product, creating steric clash in the highly
crowded active site. The shifting of α8 and rupture of the Arg291-Glu64 ion pair alleviate
this clash, creating a large cavity that presumably allows facile product dissociation.
The Arg291-Glu64 ion pair is a central player in the conformational changes observed in
DrPRODH. Because it is formed in the closed E-S complex and broken in the ligand-free
state, the ion pair appears to function as the active site gate. Since the ion pairing residues
are identically conserved in monofunctional PRODHs and PutAs, we suggest that the gate is
a universal aspect of PRODH catalysis.
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Whereas the ion pair gate opens to the bulk medium in DrPRODH, the gate of PutA
separates the proline binding site from a large, internal cavity that traverses 41 Å to the
P5CDH active site.20 This cavity serves as a conduit through which P5C/GSA is channeled
to the P5CDH active site. In the structure of full-length Bradyrhizobium japonicum PutA,
the gate is closed and a sulfate ion is bound in the PRODH active site. A structure of this
enzyme with the proline site empty is not available, but based on the DrPRODH structures
we predict that reduction of the FAD in PutA opens the gate allowing P5C/GSA to enter the
substrate-channeling cavity. Curiously, dithionite-reduction of crystalline PutA86-669THFA does not break the ion pair, although the flavin conformation is altered as in
DrPRODHr.28 It is possible that crystal contacts inhibit rupture of the gate in crystalline
PutA86-669. Clearly, new structures of full-length PutAs are needed to understand how the
ion pair gate functions in PutA.
The structural changes observed in DrPRODH perhaps also provide insight into functional
switching of trifunctional PutAs. Trifunctional PutA is a type of flavin switch protein that
serves as a transcriptional repressor of the put regulon in addition to having PRODH and
P5CDH catalytic activities.31 How trifunctional PutA switches from being a DNA-bound
Biochemistry. Author manuscript; available in PMC 2013 December 18.

Luo et al.

Page 9

$watermark-text

transcriptional repressor to membrane-associated bifunctional enzyme (aka functional
switching) is a major question in PutA biochemistry. Recent rapid reaction kinetic
measurements of the paradigmatic trifunctional PutA from E. coli revealed an isomerization
step that occurs after reduction of FAD, and this step was proposed to report on flavindependent, global conformational changes that drive functional switching.32 Since rupture of
the ion pair gate and movement of α8 occur after flavin reduction in DrPRODH, it is
possible that analogous changes are also part of functional switching. Because α8 and the
β1-α1 loop contact other structural elements in PutA that are absent in monofunctional
PRODHs, rupture of the ion pair and shifting of α8 in trifunctional PutA could help initiate
a cascade of events that eventually leads to a larger, more global isomerization of the protein
that unveils a high affinity membrane-association domain.
Finally, although it was not possible to crystallize DrPRODH in the absence of THFA,
presumably the active site of the oxidized enzyme is open prior to substrate binding (state I
in Figure 1B). Indeed, this is true for TtPRODH. The structure of oxidized, ligand-free
TtPRODH resembles DrPRODHr in that the ion pair gate is open and α8 is shifted away
from the isoalloxazine (Figure 2B). In fact, the shift of α8 in TtPRODH is 1.3. Å larger than
that of DrPRODHr (Figure 2B). Whether substrate binding to the open enzyme induces
closure of the gate (induced fit) or the substrate binds to closed-like conformations that arise
from thermal fluctuations (conformational selection) remains to be determined. However,
the large conformational changes that are required to form the closed E-S complex seem to
favor conformational selection as a plausible mechanism for substrate binding.33
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ABBREVIATIONS
PRODH

proline dehydrogenase

P5C

1-pyrroline-5-carboxylate

GSA

glutamate semialdehyde

P5CDH

1-pyrroline-5-carboxylate dehydrogenase

POX

human proline oxidase

TtPRODH

proline dehydrogenase from Thermus thermophilus

PutA

proline utilization A

DrPRODH

proline dehydrogenase from Deinococcus radiodurans R1
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DrPRODHo

oxidized proline dehydrogenase from Deinococcus radiodurans R1

DrPRODHr

reduced proline dehydrogenase from Deinococcus radiodurans R1

THFA

L-tetrahydrofuroic acid

CoQ1

Coenzyme Q1

TEVP

Tobacco Etch Virus protease

PutA86-669

PRODH construct of E. coli PutA containing residues 86-669
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Figure 1.

(A) Reactions catalyzed by PRODH and P5CDH. (B) Scheme showing the enzyme states
that occur during the PRODH reductive half-reaction.
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Figure 2.

Overall fold of PRODH. (A) Two views of the DrPRODHo-THFA structure. The backbone
is colored according to a rainbow scheme, with blue at the N-terminus and red at the Cterminus. FAD is colored yellow. THFA is colored pink. Residue numbers of the N- and Ctermini are noted. (B) Superposition of DrPRODHo-THFA (yellow), DrPRODHr (gray), and
TtPRODH (cyan, PDB code 2g37). The R291-E64 ion pair is observed only in the
DrPRODHo-THFA structure. This figure and others were prepared with PyMOL.36
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The active site of DrPRODHo-THFA (relaxed stereographic views). (A) Electron density
map for DrPRODHo-THFA. The cage represents a simulated annealing sA-weighted Fo - Fc
omit map (3.0 s). (B) Superposition of DrPRODHo-THFA (yellow) and PutA86-669-THFA
(gray, PDB code 1tiw), highlighting differences in the orientation of the conserved
glutamate of α8 (Glu295 in DrPRODH, Glu559 in PutA). Yellow and black dashes denote
the unique electrostatic interactions of DrPRODH and PutA86-669, respectively.
Conformations A and B of the FAD in DrPRODHo-THFA are colored yellow and pink,
respectively.
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Figure 4.

Conformations of the flavin in DrPRODH (relaxed stereographic views). (A) The dual FAD
conformations of DrPRODHo-THFA. Conformations A (q = 0.56) and B (q = 0.44) are
colored yellow and pink, respectively. Yellow and red dashes denote the unique hydrogen
bonds of conformations A and B, respectively. Note that the two conformations differ
mainly in the orientations of the 2′-OH and 3′-OH groups of the ribityl. (B and C) Two
views of the dithionite-reduced flavin of DrPRODHr. In all three panels, the cage represents
a simulated annealing sA-weighted Fo - Fc omit map (3.0 s).
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Figure 5.

Comparison of flavin conformations in PRODHs and PutAs. (A) Superposition FAD
conformation A of DrPRODHo-THFA (yellow) and the FAD of PutA86-669-THFA
(salmon, PDB code 1tiw). (B) Superposition of FAD conformation B of DrPRODHo-THFA
(pink) and the oxidized flavin of TtPRODH (cyan, PDB code 2g37). (C) Superposition of
the reduced flavin of DrPRODHr (gray), the oxidized FAD of TtPRODH (cyan), and the
inactivated flavin of the PutA PRODH domain (magenta, PDB code 3ITG).

Biochemistry. Author manuscript; available in PMC 2013 December 18.

Luo et al.

Page 17

$watermark-text
$watermark-text
$watermark-text

Figure 6.

Conformational changes induced by flavin reduction and product release. (A) Superposition
of the active sites of DrPRODHo-THFA (yellow) and DrPRODHr (gray) highlighting the
shift of α8, reconfiguration of the β1-α1 loop, and breaking of the Arg291-Glu64 ion pair.
Black dashes indicate electrostatic interactions in DrPRODHo-THFA. (B) Surface
representation of DrPRODHo-THFA. FAD and THFA are drawn as spheres in yellow and
pink, respectively. Glu64 and Arg291 are colored red and blue, respectively. Glu295 is
colored green. The inset shows a view from the bottom of the active site. (C) Surface
representation of DrPRODHr. The coloring is the same as in panel B. The dashes outline the
openings to the active site.
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TABLE 1
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X-ray Diffraction Data Collection and Refinementa
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DrPRODHo-THFA

DrPRODHr

FAD redox state

oxidized

reduced

Space group

P212121

P212121

Unit cell parameters (Å)

a = 44.5, b = 95.5, c = 136.4

a = 43.4, b = 95.7, c = 136.0

Wavelength

0.979

1.00

Resolution (Å)

95.5 – 1.36 (1.43 – 1.36)

47.8 – 1.75 (1.84 – 1.75)

Observations

450935

415890

Unique reflections

124272

58089

Rmerge(I)

0.032 (0.431)

0.065 (0.837)

Rmeas(I)

0.043 (0.576)

0.071 (0.905)

Rpim(I)

0.021 (0.294)

0.026 (0.341)

Mean I/σ

17.1 (2.4)

22.1 (2.5)

Completeness (%)

98.9 (98.5)

100.0 (100.0)

Multiplicity

3.6 (3.7)

7.2 (7.0)

No. of protein residues

562

550

No. of atoms

5091

4557

No. of FAD atoms

212

106

No. of THFA atoms

16

0

No. of water molecules

475

297

Rcryst

0.148 (0.239)

0.182 (0.276)

Rfreeb

0.181 (0.279)

0.213 (0.323)

rmsd bond lengths (Å)c

0.015

0.013

rmsd bond angles (°)

1.75

1.45

Favored (%)

99.3

99.3

Allowed (%)

0.7

0.7

Outliers (%)

0.0

0.0

Protein

21.4

28.6

FAD

17.7

23.7

THFA

17.5

n/a

Acetate

n/a

26.2

Water

31.5

31.4

Coordinate error (Å)e

0.14

0.19

PDB code

4H6Q

4H6R

Ramachandran plotd

Average B

(Å2)

a

Values for the outer resolution shell of data are given in parenthesis.

b

A common test set (5 %) was used for refinement of both structures.

c

Compared to the parameters of Engh and Huber.34
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d

The Ramachandran plot was generated with RAMPAGE.35

e

Maximum likelihood-based coordinate error estimate.
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TABLE 2

Kinetic Parameters for DrPRODH and DrPRODH Mutant Enzymes Using Proline and CoQ1 as the Substrates
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kcat (s−1)

Km (mM)

kcat/Km (s−1 M−1)

Variational Effect (kcat/Km of mutant)/(kcat/Km of DrPRODH)

Proline as the variable substratea
DrPRODH

8.7 ± 0.58

290 ± 39

30 ± 4.5

G63A

0.080 ± 0.006

384 ± 68

0.21 ± 0.04

0.007 ± 0.002

E64A

0.055 ± 0.001

50 ± 6

1.1 ± 0.13

0.037 ± 0.007

CoQ1 as the variable substrateb
DrPRODH

14 ± 1

0.155 ± 0.04

90323 ± 24185

G63A

0.043 ± 0.003

0.028 ± 0.01

1535 ± 559

0.017 ± 0.008

E64A

0.046 ± 0.003

0.032 ± 0.01

1438 ± 458

0.016 ± 0.007
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a

[CoQ1] was fixed at 200 μM.

b

[Proline] was fixed at 500 mM.
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